# Johnson & Johnson (JNJ) — Q1-2023 Earnings Results

**Report date:** 2023-04-18 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2023

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.68 | N/A | +6.94% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a positive outlook on the company's ability to navigate current market conditions. They focused on maintaining strong performance in their core business areas.

**Key quotes:**

> Management highlighted strong performance in key segments despite market challenges.

> They emphasized ongoing commitment to innovation and operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report shows that Johnson & Johnson had a solid quarter in terms of earnings per share, exceeding expectations. However, the lack of revenue data and stock reaction details makes it difficult to assess overall market sentiment. Investors will be looking for more information in future reports to gauge the company's performance trajectory.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2023_